JurisdictionsTopicsUpdatesWorkflowsCompareChat with ExpertMarketplacePricing
🇮🇹🏛️

Regulatory Hierarchy

Italian regulatory structure for medicinal cannabis

Regulatory Structure Verified 2026-04-20

Workflow steps

  1. AIFA — Agenzia Italiana del Farmaco
    Primary pharmaceutical regulator. Issues import authorizations, EU-GMP certificates, manages product registration for medicinal cannabis. Italy's EU-GMP enforcement authority.
    • Import authorizations for pharmaceutical-grade cannabis
    • EU-GMP certification and inspections
    • Product registration (AIC)
    • Pharmacovigilance
  2. Ministero della Salute — Ministry of Health
    Sets national medicinal cannabis policy. Oversees AIFA. Established domestic production via SCFM (Military Pharmaceutical Chemical Plant) to address chronic shortages from import dependency.
    • National medicinal cannabis policy
    • Oversight of AIFA
    • EU treaty obligations
  3. SCFM — Stabilimento Chimico Farmaceutico Militare — Florence
    Military Pharmaceutical Chemical Plant in Florence. Italy's ONLY authorized domestic producer. Near-monopoly on domestic supply. Manufactures and distributes FM2 cannabis flos via the SSN (National Health Service).
    • Italian GMP (BPF) for domestic production
    • FM2 cannabis flos manufacturing
    • SSN distribution
    • Ministry of Defense authorization
  4. SSN Regions — Servizio Sanitario Nazionale — regional reimbursement varies
    National Health Service distributes via regional health authorities. Reimbursement varies significantly by region: Toscana and Sicilia cover medicinal cannabis; other regions require out-of-pocket payment. This regional variation is a major access barrier.
    • Regional health authority registration
    • Prescription from authorized physician
    • Reimbursement policy varies by region
  5. Pharmacies — Dispensing against physician prescription
    Italian pharmacies dispense medicinal cannabis (SCFM FM2 or imported products) against physician prescriptions. Historical severe supply shortages have been a significant problem.
    • Italian pharmacy license
    • Narcotic dispensing authorization
    • Physician prescription required
  6. Patients — End recipients — historical severe shortages
    Patients receiving medicinal cannabis via SSN. Italy has experienced severe and persistent supply shortages, primarily due to SCFM's limited production capacity. Private imports help fill the gap but are costly.
Import Authorization